| 产品详情 |
| Edit |   |
|---|
| Product Name | Clozapine N-oxide |
|---|
| Description | Metabolite of clozapine (Cat. No. 0444). Activates human muscarinic designer receptors (DREADDs) in vitro. Silences hippocampal neurons expressing hM4 DREADDs in vitro. Activates Gs-linked DREADDS- AgRP in mice via intracerebroventricular (i.c.v) injection. Shown to be a P-glycoprotein (P-gp) efflux pump substrate. Other potent and selective hM3Dq DREADD agonists available: DREADD agonist 21 and Perlapine. Water soluble salt also available. This product contains 1 molar equivalent of ethanol.. Purity 99%. MW (observed): 342.82 |
|---|
| Size | 50 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | 8-Chloro-11-(4-methyl-4-oxido-1-piperazinyl)-5H-dibenzo[b,e][1,4]diazepine |
|---|
| Gene, Accession, CAS # | CAS: 34233-69-7 |
|---|
| Catalog # | 4936/50 |
|---|
| Price | |
|---|
| Order / More Info | Clozapine N-oxide from TOCRIS BIOSCIENCE
|
|---|
| Product Specific References | PubMed: 26758850, 26974347, 27866960, 27939976, 28106041, 28538173, 28584117, 28602353, 28658323, 28684275, 29356147, 29410218, 30301899, 30833673 |
|---|
| 产品资料 |
|
|